Blog

Lack of Efficacy in Veterinary Pharmacovigilance: A Failure That Is Also a Report

In veterinary pharmacovigilance, failure to work is not just a quality complaint. When a medicine does not deliver the expected effect despite correct use, it[…]

Veterinary Vaccines: Why the Immunological Dossier Needs Its Own Strategy

A vaccine is not a pharmaceutical with an antigen instead of a chemical. Its quality, safety and efficacy evidence, the way it is released and[…]

Autogenous Veterinary Vaccines: What the Exemption Covers

Autogenous vaccines are made from the pathogens of a specific herd and used in that herd. Regulation (EU) 2019/6 allows them outside the marketing authorisation[…]

Generic and Hybrid Veterinary Medicines: Articles 18 and 19 Compared

A generic veterinary medicine can rely on the reference product’s data, but only if it truly behaves like a generic. When it does not, Regulation[…]

What Goes Into the Union Pharmacovigilance Database: Veterinary Reporting Scope

Veterinary pharmacovigilance covers much more than an animal that reacts badly to a product. Under Regulation (EU) 2019/6, the Union Pharmacovigilance Database is the single[…]

Veterinary Signal Management: The Annual Cycle MAHs Must Run

Under Regulation (EU) 2019/6, spotting a safety signal is no longer an informal exercise. Marketing authorisation holders (MAHs), national authorities and EMA share the job,[…]

Homeopathic Veterinary Medicines: Registration Under Article 86 and Its Limits

Homeopathic veterinary medicines can reach the market through a simplified registration rather than a full marketing authorisation. Regulation (EU) 2019/6 sets firm boundaries, and products[…]

Manufacturing and Import Authorisations for Veterinary Medicines: Articles 88 and 90

Anyone who manufactures, finishes, tests, releases or imports veterinary medicines in the EU needs a manufacturing authorisation. Regulation (EU) 2019/6 defines the scope broadly, and[…]

Parallel Trade in Veterinary Medicines: Common Origin, Notification and Article 102

Regulation (EU) 2019/6 gives parallel trade in veterinary medicines a clear legal basis for the first time at EU level. Article 102 sets the conditions,[…]

Advertising Veterinary Medicines Under Article 119: Rules for Promotion and Samples

Promotion of veterinary medicines is tightly bounded by Regulation (EU) 2019/6. Article 119 sets the conditions for what may be advertised, how, and what may[…]

1 … 6 7 8 9 10 … 34